Anteris Technologies Stock Fundamentals

AMEUF Stock  USD 9.05  1.55  20.67%   
Anteris Technologies fundamentals help investors to digest information that contributes to Anteris Technologies' financial success or failures. It also enables traders to predict the movement of Anteris Pink Sheet. The fundamental analysis module provides a way to measure Anteris Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anteris Technologies pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Anteris Technologies Company Shares Outstanding Analysis

Anteris Technologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Anteris Technologies Shares Outstanding

    
  13.9 M  
Most of Anteris Technologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anteris Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Anteris Technologies has 13.9 M of shares currently outstending. This is 92.3% lower than that of the Healthcare sector and 92.05% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 97.57% higher than that of the company.

Anteris Technologies Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anteris Technologies's current stock value. Our valuation model uses many indicators to compare Anteris Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anteris Technologies competition to find correlations between indicators driving Anteris Technologies's intrinsic value. More Info.
Anteris Technologies is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anteris Technologies' earnings, one of the primary drivers of an investment's value.

Anteris Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anteris Technologies' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Anteris Technologies could also be used in its relative valuation, which is a method of valuing Anteris Technologies by comparing valuation metrics of similar companies.
Anteris Technologies is currently under evaluation in shares outstanding category among its peers.

Anteris Fundamentals

About Anteris Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Anteris Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anteris Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anteris Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Anteris Technologies Ltd operates as a structural heart company. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Admedus operates under Medical Devices classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in Anteris Pink Sheet

Anteris Technologies financial ratios help investors to determine whether Anteris Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anteris with respect to the benefits of owning Anteris Technologies security.